ONCR || Lymphoma and Plasma Cell Disorders

Exercise may lower risk for non-Hodgkin’s lymphoma

Posted on: 01/05/2015 - 15:35

Vigorous physical activity may help lower the risk of non-Hodgkin’s lymphoma, Terry Boyle, Ph.D., and his coauthors reported in Cancer Epidemiology,... More »

Field of Interest: Oncology

Type: News Item

Chemotherapy and stem-cell transplantation combination appears safe

Posted on: 13/04/2015 - 21:00

In a population of patients with hematologic malignancies who refuse blood product transfusions, high-dose chemotherapy (HDC) followed by autologous s... More »

Field of Interest: Oncology

Type: News Item

Game-changing study could end exclusion for HIV-related lymphomas

Posted on: 08/12/2014 - 20:17

SAN FRANCISCO – Autologous hematopoietic stem cell transplantation should be offered to patients with HIV-related lymphomas and treatment-responsive HIV infection, results from a new study...

Field of Interest: Oncology

Type: News Item

Brentuximab changes landscape for post-transplant Hodgkin’s lymphoma patients

Posted on: 07/12/2014 - 17:32

SAN FRANCISCO – Early post-transplant brentuximab vedotin dramatically slows Hodgkin’s lymphoma progression in patients at high risk for relapse or progression, the phase III AETHERA study...

Field of Interest: Oncology

Type: News Item

FDA panel votes against panobinostat as add-on therapy for multiple myeloma

Posted on: 07/11/2014 - 11:34

SILVER SPRING, MD. – The majority of a Food and Drug Administration advisory panel agreed that the risk-benefit profile of panobinostat as add-on treatment to bortezomib and dexamethasone did not...

Field of Interest: Oncology

Type: News Item

AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics

Posted on: 29/04/2014 - 21:20

PHILADELPHIA – Few templates exist for creating a pediatric oncofertility clinic, particularly in the context of the nascent trend of pediatric oncologists treating adults with pediatric cancers....

Field of Interest: Oncology

Type: News Item

AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics

Posted on: 29/04/2014 - 21:20

Field of Interest: Pulmonology

Type: News Item

Approval of mercaptopurine suspension will facilitate pediatric dosing

Posted on: 29/04/2014 - 18:30

More than 60 years after it first became available as a 50-mg tablet, an oral suspension formulation of mercaptopurine has been approved by the Food and Drug Administration. The oral suspension...

Field of Interest: Oncology

Type: News Item

Exercise may lower risk for non-Hodgkin’s lymphoma

Chemotherapy and stem-cell transplantation combination appears safe

Game-changing study could end exclusion for HIV-related lymphomas

Brentuximab changes landscape for post-transplant Hodgkin’s lymphoma patients

FDA panel votes against panobinostat as add-on therapy for multiple myeloma

AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics

AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics

Approval of mercaptopurine suspension will facilitate pediatric dosing

Newsletters

Latest Newsletters

You are here

ONCR || Lymphoma and Plasma Cell Disorders

Newsletters

Latest Newsletters